The 3D-TGA model demonstrates significantly higher chemo-resistance in the models incorporating mesenchymal support in a drug and patient dependent manner.
Sensitivity of close-to-patient cells was determined in 3D-TGA, after 4 day exposure to drug combinations at a range of concentrations, using the alamarBlue assay to measure viability. Viability curves were generated and IC 50 values plotted using 
ONLINE SUPPLEMENTARY METHODS

S1: Tissue Transfer and Disaggregation
Fresh endoscopic biopsy samples and surgical material was immediately placed into tissue transfer media (Dulbecco's modified Eagle's medium with 10% foetal bovine serum, 1% 0.2 M L-glutamine, 1% penicillin / streptomycin / amphotericin B, 0.1% 1 mg/ml hydrocortisone, 0.75% 1 mg/ml insulin) at 4 o C, and transferred to the laboratory, and processed within 4-6 hours. On arrival at the laboratory, the tumour material was dissected; the majority of the tissue was finely minced for live use, and further small portions were either formalinfixed and paraffin-embedded (FFPE) for immunohistochemistry (IHC), or stored in RNAlater (Ambion) for subsequent analysis. The finely-minced tumour was disaggregated using type II collagenase (100 U/ml, Gibco, ThermoFisher Scientific) and dispase (2.4 U/ml, Gibco, ThermoFisher Scientific) in Hank's balanced salt solution (HBSS) without calcium or magnesium (Sigma) at 37C under constant rotation. Cells were removed at 1-2 hourly intervals until the tumour was completely disaggregated. 
S3: Murine xenograft Tumourigenicity Assay
Individual patient cancer epithelial cells (2x10 6 cells) were admixed (in a 2:1 tumour:stroma ratio) with low passage bone marrow-derived mesenchymal stem cells (hMSCs) (1x10 6 cells) (ScienCell) in 100 μl medium and suspended in 100 μl cold Matrigel (BD Biosciences, Germany). This was injected subcutaneously into the right and left flanks of sex-matched 6-8 weeks old MF-1 nude or RAG mice (Harlan).
Animal procedures were carried out with ethical approval under UK Home Office Licence (PPL 40/3559) in accordance with the 3R's framework for humane animal research. Tumour growth from the cell injections was monitored by caliper measurements, until they had reached the maximum acceptable size, when tumours were surgically removed under anaesthesia and portioned for histological examination, cryopreservation and reimplantation.
S4: 3D-TGA Method
The 3D-TGA method was performed as previously described, [1, 2] and adjusted to take account of the 384-well plate format (for 6 repeated wells per condition) and the higher concentration of modified Cultrex BME. In brief; 6.25x10 3 tumour cells and 3.125 x10 (Corning, New York, USA). Once embedded in the 3D matrix and brought to room temperature, a media overlay of 12.5 µl per well was used for cell clusters nutrition.
Plates were incubated for 72 hours to allow cells to establish within the extracellular matrix and form cell clusters. These were then treated with increasing concentrations of the chemotherapy drugs as a 12.5 µl media overlay per well, to enable endpoint drug sensitivity. Following 96 hours exposure, growth was assessed using a 12.5 µl per well overlay alamarBlue® assay, and evaluated using a fluorescent plate reader.
S5: Establishment of mCherry-labelled hMSCs
Low passage hMSCs were seeded in 6-well plates (2x10 5 cells/ well) and left to adhere overnight before being transduced with mCherry (Clontech Lentiviral X containing mCherry under the control of CMV IE promoter), according to the manufactures instructions. Transduced cells were selected by exposing cells to puromycin at a concentration shown to kill parental cells (1g/ml). Selection was maintained for a week. Surviving cells were expanded, expression of mCherry determined by flow cytometry, and aliquots of the low passage mCherry-labelled hMSCs cryopreserved for subsequent use.
S6: IHC Methodology
Following optimisation, staining was undertaken in batches for each antigen with the corresponding negative controls, in line with previous reports in the published literature. In brief; slides were de-paraffinised and underwent heat induced epitope retrieval. Following equilibration in phosphate-buffered saline (PBS) the endogenous peroxidase activity was blocked by incubating slides in a solution of hydrogen peroxide in PBS. Endogenous proteins were blocked with the serum corresponding to the secondary antibody, before incubation with the primary antibody in question. Amplification and visualisation was then performed either with streptavidin-biotin-peroxidase or horseradish-peroxidase (HRP) technique with diaminobenzidine (DAB), which becomes visible as a brown precipitate. Finally, slides were counter-stained with haematoxylin before mounting.
